OpenBots is a significant player in the application layer of the AI agent ecosystem, specifically within the healthcare vertical. They represent a shift from traditional Robotic Process Automation (RPA) to agentic workflows, where agents move from following fixed scripts to using LLM reasoning to handle variable business logic in revenue cycles.
Their relevance to the agent stack is most apparent in their "surface automation" capabilities. This serves as a vital sensory and motor layer for agents in environments where APIs are non-existent. By proving that agents can handle high-stakes, regulated tasks like prior authorization and insurance billing, OpenBots provides a blueprint for how autonomous agents can be integrated into legacy enterprise sectors.
OpenBots is an automation technology provider focused on the healthcare revenue cycle. Headquartered in Sunrise, Florida, the company develops the Coordio Healthcare platform, which manages administrative tasks that traditionally require manual intervention from hospital staff. These tasks include patient intake, insurance eligibility verification, and the management of medical claims and denials.
The healthcare sector is known for fragmented technical infrastructure. OpenBots addresses this by using a dual-track integration strategy. For modern Electronic Medical Record (EMR) systems, the platform connects through FHIR (Fast Healthcare Interoperability Resources) APIs. To handle the significant portion of the market still running on legacy software without API access, the company employs "surface automation." This technology allows AI agents to interact with software interfaces by simulating human clicks and reading text on screen, effectively giving LLM-driven agents the ability to operate aging software.
The company’s trajectory is marked by a shift from horizontal automation to vertical specialization. OpenBots launched its general automation platform in 2022 but quickly narrowed its focus to the healthcare market. Since then, they have deployed specific agents for high-friction tasks like fax indexing and classification. In the medical field, where faxing remains a primary method of document exchange, these agents are used to read, categorize, and enter faxed data into digital records automatically. In late 2024 and early 2025, the company expanded this logic to cover the entire revenue cycle, from initial claims to final collections.
Founded by Zia Bhutta and Ashish Nangla, OpenBots has moved toward a full-stack service model. Bhutta, who is CEO, has overseen the development of agents that handle the "front-end" of the medical office (patient eligibility) and the "back-end" (denials management). A notable strategic move was the 2025 acquisition of Neomed RCM Billing Services. This acquisition suggests a transition from selling software tools to providing an automated billing service where agents perform the work previously handled by human billing specialists.
OpenBots competes in a market occupied by massive legacy RCM vendors and a growing number of AI-native startups. Their differentiation lies in the "AI-first" architecture of Coordio. Rather than adding AI features to existing database software, OpenBots built Coordio to be autonomous from the start. This approach allows their agents to execute complex business logic, such as navigating the appeals process for a denied insurance claim, without constant human oversight. Current users of the platform include healthcare organizations such as InfuSystem, Borland Groover, and Deer Oaks, who use the system to reduce administrative errors and accelerate the reimbursement cycle.
An AI-first RCM automation platform for healthcare providers.
OpenBots is hiring.